Joel Greenblatt's CNMD Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 49,134 shares of CONMED Corporation (CNMD) worth $1.74 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 43 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in CNMD, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2014, adding 154,980 shares. Largest reduction occurred in Q3 2014, reducing 168,447 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's CONMED Corporation (CNMD) Holding Value Over Time
Track share changes against reported price movement
Quarterly CONMED Corporation (CNMD) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -1,214 | Reduce 2.41% | 49,134 | $35.36 |
| Q4 2025 | -312 | Reduce 0.62% | 50,348 | $40.60 |
| Q3 2025 | +6,164 | Add 13.85% | 50,660 | $47.03 |
| Q2 2025 | +44,496 | New Buy | 44,496 | $52.08 |
| Q1 2025 | -4,570 | Sold Out | 0 | $0.00 |
| Q4 2024 | +4,570 | New Buy | 4,570 | $68.44 |
| Q3 2024 | -15,158 | Sold Out | 0 | $0.00 |
| Q2 2024 | -20,416 | Reduce 57.39% | 15,158 | $69.32 |
| Q1 2024 | +1,555 | Add 4.57% | 35,574 | $80.08 |
| Q4 2023 | +10,558 | Add 45.00% | 34,019 | $109.51 |
| Q3 2023 | +15,497 | Add 194.59% | 23,461 | $100.85 |
| Q2 2023 | +2,469 | Add 44.93% | 7,964 | $135.89 |
| Q1 2023 | -244 | Reduce 4.25% | 5,495 | $103.86 |
| Q4 2022 | +2,637 | Add 85.01% | 5,739 | $88.64 |
| Q2 2022 | -92 | Reduce 2.88% | 3,102 | $95.74 |
| Q1 2022 | -5 | Reduce 0.16% | 3,194 | $148.40 |
| Q4 2021 | -6,483 | Reduce 66.96% | 3,199 | $141.61 |
| Q3 2021 | +5,300 | Add 120.95% | 9,682 | $130.86 |
| Q2 2021 | -1,939 | Reduce 30.68% | 4,382 | $137.38 |
| Q1 2021 | -6,516 | Reduce 50.76% | 6,321 | $130.52 |
| Q4 2020 | -2,091 | Reduce 14.01% | 12,837 | $112.02 |
| Q3 2020 | -21,251 | Reduce 58.74% | 14,928 | $78.64 |
| Q2 2020 | -11,452 | Reduce 24.04% | 36,179 | $72.00 |
| Q1 2020 | +16,944 | Add 55.22% | 47,631 | $57.27 |
| Q4 2019 | +30,687 | New Buy | 30,687 | $111.84 |
| Q2 2019 | -11,460 | Sold Out | 0 | $0.00 |
| Q1 2019 | -7,356 | Reduce 39.09% | 11,460 | $83.16 |
| Q4 2018 | -85,515 | Reduce 81.97% | 18,816 | $64.20 |
| Q3 2018 | +33,022 | Add 46.31% | 104,331 | $79.22 |
| Q2 2018 | +39,767 | Add 126.08% | 71,309 | $73.20 |
| Q1 2018 | -16,743 | Reduce 34.68% | 31,542 | $63.34 |
| Q4 2017 | -29,157 | Reduce 37.65% | 48,285 | $50.97 |
| Q3 2017 | +5,475 | Add 7.61% | 77,442 | $52.47 |
| Q2 2017 | +31,283 | Add 76.89% | 71,967 | $50.94 |
| Q1 2017 | +29,078 | Add 250.54% | 40,684 | $44.42 |
| Q4 2016 | +11,606 | New Buy | 11,606 | $44.20 |
| Q3 2014 | -168,447 | Sold Out | 0 | $0.00 |
| Q2 2014 | +154,980 | Add 1150.81% | 168,447 | $44.15 |
| Q1 2014 | +13,467 | New Buy | 13,467 | $43.44 |
| Q4 2013 | -19,019 | Sold Out | 0 | $0.00 |
| Q3 2013 | -29,759 | Reduce 61.01% | 19,019 | $33.97 |
| Q2 2013 | +48,778 | Add 0.00% | 48,778 | $31.24 |
Joel Greenblatt's CONMED Corporation Investment FAQs
Joel Greenblatt first purchased CONMED Corporation (CNMD) in Q2 2013, acquiring 48,778 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held CONMED Corporation (CNMD) for 43 quarters since Q2 2013.
Joel Greenblatt's largest addition to CONMED Corporation (CNMD) was in Q2 2014, adding 168,447 shares worth $7.44 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 49,134 shares of CONMED Corporation (CNMD), valued at approximately $1.74 M.
As of the Q1 2026 filing, CONMED Corporation (CNMD) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in CONMED Corporation (CNMD) was 168,447 shares, as reported at the end of Q2 2014.